Diagnosis and management of pulmonary nodules

References

• Mettler FA Jr, Thomadsen BR, Bhargavan M, et al. Medical radiation exposure in the U.S. in 2006: preliminary results. Health Phys 2008;95(5):502-7
   Google Scholar
• National Lung Screening Trial Research T. Aberle DR, Adams AM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365(5):395-409
   PubMed Web of Science ®Google Scholar
• Moyer VA. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2014;160(5):330-8
   PubMed Web of Science ®Google Scholar
• Ost D, Fein AM, Feinsilver SH. Clinical practice. The solitary pulmonary nodule. N Engl J Med 2003;348(25):2535-42
   PubMedGoogle Scholar
• MacMahon H, Austin JH, Gamsu G, et al. Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology 2005;237(2):395-400
   PubMed Web of Science ®Google Scholar
• Naidich DP, Bankier AA, MacMahon H, et al. Recommendations for the management of subsolid pulmonary nodules detected at CT: a statement from the Fleischner Society. Radiology 2013;266(1):304-17
   PubMed Web of Science ®Google Scholar
• Gould MK, Donington J, Lynch WR, et al. Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013;143(5 Suppl):e93S-120S
   PubMed Web of Science ®Google Scholar
• Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics. 2014. CA Cancer J Clin 2014;64(1):9-29
   PubMed Web of Science ®Google Scholar
• International Early Lung Cancer Action Program I. Henschke CI, Yankelevitz DF, et al. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 2006;355(17):1763-71
   PubMed Web of Science ®Google Scholar
• van den Bergh KA, Essink-Bot ML, Borsboom GJ, et al. Short-term health-related quality of life consequences in a lung cancer CT screening trial (NELSON). Br J Cancer 2010;102(1):27-34
   PubMedGoogle Scholar
• Wiener RS, Gould MK, Woloshin S, et al. ‘The thing is not knowing’: patients’ perspectives on surveillance of an indeterminate pulmonary nodule. Health Expect 2012. [Epub ahead of print]
   Google Scholar
• Swensen SJ, Silverstein MD, Ilstrup DM, et al. The probability of malignancy in solitary pulmonary nodules. Application to small radiologically indeterminate nodules. Arch Intern Med 1997;157(8):849-55
   PubMedGoogle Scholar
• Gould MK, Ananth L, Barnett PG; Veterans Affairs SCSG. A clinical model to estimate the pretest probability of lung cancer in patients with solitary pulmonary nodules. Chest 2007;131(2):383-8
   PubMed Web of Science ®Google Scholar
• Balekian AA, Silvestri GA, Simkovich SM, et al. Accuracy of clinicians and models for estimating the probability that a pulmonary nodule is malignant. Ann Am Thorac Soc 2013;10(6):629-35
   Google Scholar
• Tammemagi MC, Freedman MT, Pinsky PF, et al. Prediction of true positive lung cancers in individuals with abnormal suspicious chest radiographs: a prostate, lung, colorectal, and ovarian cancer screening trial study. J Thorac Oncol 2009;4(6):710-21
   Web of Science ®Google Scholar
• Oken MM, Hocking WG, Kvale PA, et al. Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial. JAMA 2011;306(17):1865-73
   PubMed Web of Science ®Google Scholar
• McWilliams A, Tammemagi MC, Mayo JR, et al. Probability of cancer in pulmonary nodules detected on first screening CT. N Engl J Med 2013;369(10):910-19
   PubMed Web of Science ®Google Scholar
• Tammemagi MC, Katki HA, Hocking WG, et al. Selection criteria for lung-cancer screening. N Engl J Med 2013;368(8):728-36
   PubMed Web of Science ®Google Scholar
• Yonemori K, Tateishi U, Uno H, et al. Development and validation of diagnostic prediction model for solitary pulmonary nodules. Respirology 2007;12(6):856-62
   PubMed Web of Science ®Google Scholar
• May BJ, Levsky JM, Godelman A, et al. Should CT play a greater role in preventing the resection of granulomas in the era of PET? Am J Roentgenol 2011;196(4):795-800
   Google Scholar
• Gould MK, Sanders GD, Barnett PG, et al. Cost-effectiveness of alternative management strategies for patients with solitary pulmonary nodules. Ann Intern Med 2003;138(9):724-35
   PubMed Web of Science ®Google Scholar
• Silvestri GA, Gonzalez AV, Jantz MA, et al. Methods for staging non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013;143(5 Suppl):e211S-50S
   PubMed Web of Science ®Google Scholar
• Fischer B, Lassen U, Mortensen J, et al. Preoperative staging of lung cancer with combined PET-CT. N Engl J Med 2009;361(1):32-9
   PubMed Web of Science ®Google Scholar
• van Tinteren H, Hoekstra OS, Smit EF, et al. Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial. Lancet 2002;359(9315):1388-93
   PubMed Web of Science ®Google Scholar
• Viney RC, Boyer MJ, King MT, et al. Randomized controlled trial of the role of positron emission tomography in the management of stage I and II non-small-cell lung cancer. J Clin Oncol 2004;22(12):2357-62
   Google Scholar
• Maziak DE, Darling GE, Inculet RI, et al. Positron emission tomography in staging early lung cancer: a randomized trial. Ann Intern Med 2009;151(4):221-8. W-248
   Google Scholar
• Morgensztern D, Waqar S, Subramanian J, et al. Improving survival for stage IV non-small cell lung cancer: a surveillance, epidemiology, and end results survey from 1990 to 2005. J Thorac Oncol 2009;4(12):1524-9
   Google Scholar
• Morgensztern D, Goodgame B, Baggstrom MQ, et al. The effect of FDG-PET on the stage distribution of non-small cell lung cancer. J Thorac Oncol 2008;3(2):135-9
   Google Scholar
• Hensing TA, Salgia R. Molecular biomarkers for future screening of lung cancer. J Surg Oncol 2013;108(5):327-33
   Google Scholar
• Roy HK, Subramanian H, Damania D, et al. Optical detection of buccal epithelial nanoarchitectural alterations in patients harboring lung cancer: implications for screening. Cancer Res 2010;70(20):7748-54
   PubMed Web of Science ®Google Scholar
• Belinsky SA, Grimes MJ, Casas E, et al. Predicting gene promoter methylation in non-small-cell lung cancer by evaluating sputum and serum. Br J Cancer 2007;96(8):1278-83
   PubMed Web of Science ®Google Scholar
• Gessner C, Rechner B, Hammerschmidt S, et al. Angiogenic markers in breath condensate identify non-small cell lung cancer. Lung Cancer 2010;68(2):177-84
   PubMed Web of Science ®Google Scholar
• Peled N, Hakim M, Bunn PA Jr, et al. Non-invasive breath analysis of pulmonary nodules. J Thorac Oncol 2012;7(10):1528-33
   PubMed Web of Science ®Google Scholar
• Krebs MG, Hou JM, Sloane R, et al. Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches. J Thorac Oncol 2012;7(2):306-15
   PubMed Web of Science ®Google Scholar
• Boyle P, Chapman CJ, Holdenrieder S, et al. Clinical validation of an autoantibody test for lung cancer. Ann Oncol 2011;22(2):383-9
   PubMed Web of Science ®Google Scholar
• Li XJ, Hayward C, Fong PY, et al. A blood-based proteomic classifier for the molecular characterization of pulmonary nodules. Sci Transl Med 2013;5(207):207ra142
   PubMed Web of Science ®Google Scholar
• Greenberg AK, Lee MS. Biomarkers for lung cancer: clinical uses. Curr Opin Pulm Med 2007;13(4):249-55
   Google Scholar
• Cagle PT, Allen TC, Olsen RJ. Lung cancer biomarkers: present status and future developments. Arch Pathol Lab Med 2013;137(9):1191-8
   PubMed Web of Science ®Google Scholar
• Bremnes RM, Sirera R, Camps C. Circulating tumour-derived DNA and RNA markers in blood: a tool for early detection, diagnostics, and follow-up? Lung Cancer 2005;49(1):1-12
   PubMed Web of Science ®Google Scholar
• Hennessey PT, Sanford T, Choudhary A, et al. Serum microRNA biomarkers for detection of non-small cell lung cancer. PLoS One 2012;7(2):e32307
   PubMed Web of Science ®Google Scholar
• Divisi D, Di Tommaso S, Di Leonardo G, et al. 18-fluorine fluorodeoxyglucose positron emission tomography with computerized tomography versus computerized tomography alone for the management of solitary lung nodules with diameters inferior to 1.5 cm. Thorac Cardiovasc Surg 2010;58(7):422-6
   Google Scholar
• Henschke CI, Yankelevitz DF, Naidich DP, et al. CT screening for lung cancer: suspiciousness of nodules according to size on baseline scans. Radiology 2004;231(1):164-8
   PubMed Web of Science ®Google Scholar
• Swensen SJ, Jett JR, Sloan JA, et al. Screening for lung cancer with low-dose spiral computed tomography. Am J Respir Crit Care Med 2002;165(4):508-13
   PubMed Web of Science ®Google Scholar
• Gohagan J, Marcus P, Fagerstrom R, et al. Baseline findings of a randomized feasibility trial of lung cancer screening with spiral CT scan vs chest radiograph: the Lung Screening Study of the National Cancer Institute. Chest 2004;126(1):114-21
   PubMed Web of Science ®Google Scholar
• Weiss W. Tumor doubling time and survival of men with bronchogenic carcinoma. Chest 1974;65(1):3-8
   Google Scholar
• Benjamin MS, Drucker EA, McLoud TC, Shepard JA. Small pulmonary nodules: detection at chest CT and outcome. Radiology 2003;226(2):489-93
   Google Scholar
• Lindell RM, Hartman TE, Swensen SJ, et al. 5-year lung cancer screening experience: growth curves of 18 lung cancers compared to histologic type, CT attenuation, stage, survival, and size. Chest 2009;136(6):1586-95
   Google Scholar
• Min JH, Lee HY, Lee KS, et al. Stepwise evolution from a focal pure pulmonary ground-glass opacity nodule into an invasive lung adenocarcinoma: an observation for more than 10 years. Lung Cancer 2010;69(1):123-6
   Google Scholar
• Goo JM, Park CM, Lee HJ. Ground-glass nodules on chest CT as imaging biomarkers in the management of lung adenocarcinoma. Am J Roentgenol 2011;196(3):533-43
   Google Scholar
• Kodama K, Higashiyama M, Yokouchi H, et al. Natural history of pure ground-glass opacity after long-term follow-up of more than 2 years. Ann Thorac Surg 2002;73(2):386-92. discussion 392-383
   Google Scholar
• Kim HY, Shim YM, Lee KS, et al. Persistent pulmonary nodular ground-glass opacity at thin-section CT: histopathologic comparisons. Radiology 2007;245(1):267-75
   PubMed Web of Science ®Google Scholar
• Mun M, Kohno T. Efficacy of thoracoscopic resection for multifocal bronchioloalveolar carcinoma showing pure ground-glass opacities of 20 mm or less in diameter. J Thorac Cardiovasc Surg 2007;134(4):877-82
   Google Scholar
• Ohtsuka T, Watanabe K, Kaji M, et al. A clinicopathological study of resected pulmonary nodules with focal pure ground-glass opacity. Eur J Cardiothorac Surg 2006;30(1):160-3
   PubMed Web of Science ®Google Scholar
• Kodama K, Higashiyama M, Takami K, et al. Treatment strategy for patients with small peripheral lung lesion(s): intermediate-term results of prospective study. Eur J Cardiothorac Surg 2008;34(5):1068-74
   PubMed Web of Science ®Google Scholar
• Hiramatsu M, Inagaki T, Inagaki T, et al. Pulmonary ground-glass opacity (GGO) lesions-large size and a history of lung cancer are risk factors for growth. J Thorac Oncol 2008;3(11):1245-50
   Google Scholar
• Swensen SJ, Jett JR, Hartman TE, et al. CT screening for lung cancer: five-year prospective experience. Radiology 2005;235(1):259-65
   PubMed Web of Science ®Google Scholar
• Lee SM, Park CM, Goo JM, et al. Transient part-solid nodules detected at screening thin-section CT for lung cancer: comparison with persistent part-solid nodules. Radiology 2010;255(1):242-51
   PubMed Web of Science ®Google Scholar
• Henschke CI, Yankelevitz DF, Mirtcheva R, et al. CT screening for lung cancer: frequency and significance of part-solid and nonsolid nodules. Am J Roentgenol 2002;178(5):1053-7
   PubMed Web of Science ®Google Scholar
• Kim TJ, Goo JM, Lee KW, et al. Clinical, pathological and thin-section CT features of persistent multiple ground-glass opacity nodules: comparison with solitary ground-glass opacity nodule. Lung Cancer 2009;64(2):171-8
   Google Scholar
• Park CM, Goo JM, Kim TJ, et al. Pulmonary nodular ground-glass opacities in patients with extrapulmonary cancers: what is their clinical significance and how can we determine whether they are malignant or benign lesions? Chest 2008;133(6):1402-9
   PubMed Web of Science ®Google Scholar
• Lee HJ, Goo JM, Lee CH, et al. Nodular ground-glass opacities on thin-section CT: size change during follow-up and pathological results. Korean J Radiol 2007;8(1):22-31
   Google Scholar
• Kim HK, Choi YS, Kim K, et al. Management of ground-glass opacity lesions detected in patients with otherwise operable non-small cell lung cancer. J Thorac Oncol 2009;4(10):1242-6
   Google Scholar
• Lee HY, Han J, Lee KS, et al. Lung adenocarcinoma as a solitary pulmonary nodule: prognostic determinants of CT, PET, and histopathologic findings. Lung Cancer 2009;66(3):379-85
   PubMed Web of Science ®Google Scholar
• Nair VS, Barnett PG, Ananth L, Gould MK; Veterans Affairs Solitary Nodule Accuracy Project Cooperative Studies G. PET scan 18F-fluorodeoxyglucose uptake and prognosis in patients with resected clinical stage IA non-small cell lung cancer. Chest 2010;137(5):1150-6
   PubMed Web of Science ®Google Scholar
• Pastorino U, Landoni C, Marchiano A, et al. Fluorodeoxyglucose uptake measured by positron emission tomography and standardized uptake value predicts long-term survival of CT screening detected lung cancer in heavy smokers. J Thorac Oncol 2009;4(11):1352-6
   Google Scholar
• Moyer VA; Force USPST. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2014;160(5):330-8
   PubMed Web of Science ®Google Scholar
• Bach PB, Mirkin JN, Oliver TK, et al. Benefits and harms of CT screening for lung cancer: a systematic review. JAMA 2012;307(22):2418-29
   PubMed Web of Science ®Google Scholar
• de Hoop B, Gietema H, van de Vorst S, et al. Pulmonary ground-glass nodules: increase in mass as an early indicator of growth. Radiology 2010;255(1):199-206
   PubMed Web of Science ®Google Scholar
• Korst RJ, Lee BE, Krinsky GA, Rutledge JR. The utility of automated volumetric growth analysis in a dedicated pulmonary nodule clinic. J Thorac Cardiovasc Surg 2011;142(2):372-7
   Google Scholar
• Maeshima AM, Tochigi N, Yoshida A, et al. Clinicopathologic analysis of multiple (five or more) atypical adenomatous hyperplasias (AAHs) of the lung: evidence for the AAH-adenocarcinoma sequence. J Thorac Oncol 2010;5(4):466-71
   Google Scholar
• Kim HK, Choi YS, Kim J, et al. Management of multiple pure ground-glass opacity lesions in patients with bronchioloalveolar carcinoma. J Thorac Oncol 2010;5(2):206-10
   Google Scholar
• Nakata M, Sawada S, Yamashita M, et al. Surgical treatments for multiple primary adenocarcinoma of the lung. Ann Thorac Surg 2004;78(4):1194-9
   Google Scholar
• Cummings SR, Lillington GA, Richard RJ. Managing solitary pulmonary nodules. The choice of strategy is a "close call". Am Rev Respir Dis 1986;134(3):453-60
   PubMed Web of Science ®Google Scholar
• Kim TJ, Lee JH, Lee CT, et al. Diagnostic accuracy of CT-guided core biopsy of ground-glass opacity pulmonary lesions. Am J Roentgenol 2008;190(1):234-9
   PubMed Web of Science ®Google Scholar
• Ng YL, Patsios D, Roberts H, et al. CT-guided percutaneous fine-needle aspiration biopsy of pulmonary nodules measuring 10 mm or less. Clin Radiol 2008;63(3):272-7
   PubMed Web of Science ®Google Scholar
• Baldwin DR, Eaton T, Kolbe J, et al. Management of solitary pulmonary nodules: how do thoracic computed tomography and guided fine needle biopsy influence clinical decisions? Thorax 2002;57(9):817-22
   Google Scholar
• Hur J, Lee HJ, Nam JE, et al. Diagnostic accuracy of CT fluoroscopy-guided needle aspiration biopsy of ground-glass opacity pulmonary lesions. Am J Roentgenol 2009;192(3):629-34
   Google Scholar
• Shimizu K, Ikeda N, Tsuboi M, et al. Percutaneous CT-guided fine needle aspiration for lung cancer smaller than 2 cm and revealed by ground-glass opacity at CT. Lung cancer 2006;51(2):173-9
   Google Scholar
• Infante M, Lutman RF, Imparato S, et al. Differential diagnosis and management of focal ground-glass opacities. Eur Respir J 2009;33(4):821-7
   Google Scholar
• Sawada S, Komori E, Nogami N, et al. Evaluation of lesions corresponding to ground-glass opacities that were resected after computed tomography follow-up examination. Lung Cancer 2009;65(2):176-9
   Google Scholar
• Dennie CJ, Matzinger FR, Marriner JR, Maziak DE. Transthoracic needle biopsy of the lung: results of early discharge in 506 outpatients. Radiology 2001;219(1):247-51
   Google Scholar
• Hiraki T, Mimura H, Gobara H, et al. Incidence of and risk factors for pneumothorax and chest tube placement after CT fluoroscopy-guided percutaneous lung biopsy: retrospective analysis of the procedures conducted over a 9-year period. Am J Roentgenol 2010;194(3):809-14
   Google Scholar
• Wiener RS, Schwartz LM, Woloshin S, Welch HG. Population-based risk for complications after transthoracic needle lung biopsy of a pulmonary nodule: an analysis of discharge records. Ann Intern Med 2011;155(3):137-44
   PubMed Web of Science ®Google Scholar
• Ayyappan AP, Souza CA, Seely J, et al. Ultrathin fine-needle aspiration biopsy of the lung with transfissural approach: does it increase the risk of pneumothorax? Am J Roentgenol 2008;191(6):1725-9
   Google Scholar
• Heyer CM, Reichelt S, Peters SA, et al. Computed tomography-navigated transthoracic core biopsy of pulmonary lesions: which factors affect diagnostic yield and complication rates? Acad Radiol 2008;15(8):1017-26
   PubMed Web of Science ®Google Scholar
• Rizzo S, Preda L, Raimondi S, et al. Risk factors for complications of CT-guided lung biopsies. Radiol Med (Torino) 2011;116(4):548-63
   Google Scholar
• Song YS, Park CM, Park KW, et al. Does antiplatelet therapy increase the risk of hemoptysis during percutaneous transthoracic needle biopsy of a pulmonary lesion? Am J Roentgenol 2013;200(5):1014-19
   Google Scholar
• Rivera MP, Mehta AC; American College of Chest P. Initial diagnosis of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007;132(3 Suppl):131S-48S
   Google Scholar
• van't Westeinde SC, Horeweg N, Vernhout RM, et al. The role of conventional bronchoscopy in the workup of suspicious CT scan screen-detected pulmonary nodules. Chest 2012;142(2):377-84
   Google Scholar
• Al-Mashhadi RH, Sorensen CB, Kragh PM, et al. Familial hypercholesterolemia and atherosclerosis in cloned minipigs created by DNA transposition of a human PCSK9 gain-of-function mutant. Sci Trans Med 2013;5(166):166ra161
   Web of Science ®Google Scholar
• Narula T, Machuzak MS, Mehta AC. Newer modalities in the work-up of peripheral pulmonary nodules. Clin Chest Med 2013;34(3):395-415
   Google Scholar
• Schreiber G, McCrory DC. Performance characteristics of different modalities for diagnosis of suspected lung cancer: summary of published evidence. Chest 2003;123(1 Suppl):115S-28S
   PubMed Web of Science ®Google Scholar
• Ost D, Shah R, Anasco E, et al. A randomized trial of CT fluoroscopic-guided bronchoscopy vs conventional bronchoscopy in patients with suspected lung cancer. Chest 2008;134(3):507-13
   Google Scholar
• Wallace JM, Deutsch AL. Flexible fiberoptic bronchoscopy and percutaneous needle lung aspiration for evaluating the solitary pulmonary nodule. Chest 1982;81(6):665-71
   Google Scholar
• Fletcher EC, Levin DC. Flexible fiberoptic bronchoscopy and fluoroscopically guided transbronchial biopsy in the management of solitary pulmonary nodules. West J Med 1982;136(6):477-83
   Google Scholar
• Chechani V. Bronchoscopic diagnosis of solitary pulmonary nodules and lung masses in the absence of endobronchial abnormality. Chest 1996;109(3):620-5
   Google Scholar
• Steinfort DP, Khor YH, Manser RL, Irving LB. Radial probe endobronchial ultrasound for the diagnosis of peripheral lung cancer: systematic review and meta-analysis. Eur Respir J 2011;37(4):902-10
   PubMed Web of Science ®Google Scholar
• Lin CY, Lan CC, Wu YK, et al. Factors that affect the diagnostic yield of endobronchial ultrasonography-assisted transbronchial lung biopsy. J Laparoendosc Adv Surg Tech A 2012;22(4):319-23
   Google Scholar
• Fielding DI, Robinson PJ, Kurimoto N. Biopsy site selection for endobronchial ultrasound guide-sheath transbronchial biopsy of peripheral lung lesions. Intern Med J 2008;38(2):77-84
   Google Scholar
• Gex G, Pralong JA, Combescure C, et al. Diagnostic yield and safety of electromagnetic navigation bronchoscopy for lung nodules: a systematic review and meta-analysis. Respiration 2014;87(2):165-76
   PubMed Web of Science ®Google Scholar
• Eberhardt R, Anantham D, Ernst A, et al. Multimodality bronchoscopic diagnosis of peripheral lung lesions: a randomized controlled trial. Am J Respir Crit Care Med 2007;176(1):36-41
   PubMed Web of Science ®Google Scholar
• Eberhardt R, Morgan RK, Ernst A, et al. Comparison of suction catheter versus forceps biopsy for sampling of solitary pulmonary nodules guided by electromagnetic navigational bronchoscopy. Respiration 2010;79(1):54-60
   PubMed Web of Science ®Google Scholar
• Oki M, Saka H, Kitagawa C, et al. Novel thin bronchoscope with a 1.7-mm working channel for peripheral pulmonary lesions. Eur Respir J 2008;32(2):465-71
   Google Scholar
• Asano F, Matsuno Y, Shinagawa N, et al. A virtual bronchoscopic navigation system for pulmonary peripheral lesions. Chest 2006;130(2):559-66
   PubMed Web of Science ®Google Scholar
• Shinagawa N, Yamazaki K, Onodera Y, et al. Factors related to diagnostic sensitivity using an ultrathin bronchoscope under CT guidance. Chest 2007;131(2):549-53
   Google Scholar
• Asano F, Shinagawa N, Ishida T, et al. Virtual bronchoscopic navigation combined with ultrathin bronchoscopy. A randomized clinical trial. Am J Respir Crit Care Med 2013;188(3):327-33
   PubMed Web of Science ®Google Scholar
• Wang Memoli JS, Nietert PJ, Silvestri GA. Meta-analysis of guided bronchoscopy for the evaluation of the pulmonary nodule. Chest 2012;142(2):385-93
   PubMed Web of Science ®Google Scholar
• Van’t Westeinde SC, Horeweg N, De Leyn P, et al. Complications following lung surgery in the Dutch-Belgian randomized lung cancer screening trial. Eur J Cardiothorac Surg 2012;42(3):420-9
   Google Scholar
• Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 1995;60(3):615-22. discussion 622-613
   PubMed Web of Science ®Google Scholar
• Mery CM, Pappas AN, Bueno R, et al. Similar long-term survival of elderly patients with non-small cell lung cancer treated with lobectomy or wedge resection within the surveillance, epidemiology, and end results database. Chest 2005;128(1):237-45
   PubMed Web of Science ®Google Scholar
• Okada M. Radical sublobar resection for small-diameter lung cancers. Thorac Surg Clin 2013;23(3):301-11
   Google Scholar
• Kodama K, Doi O, Higashiyama M, Yokouchi H. Intentional limited resection for selected patients with T1 N0 M0 non-small-cell lung cancer: a single-institution study. J Thorac Cardiovasc Surg 1997;114(3):347-53
   Google Scholar
• Okada M, Yoshikawa K, Hatta T, Tsubota N. Is segmentectomy with lymph node assessment an alternative to lobectomy for non-small cell lung cancer of 2 cm or smaller? Ann Thorac Surg 2001;71(3):956-60. Discussion 961
   PubMed Web of Science ®Google Scholar